Health · 4 views
Bariatric surgery is effective rescue strategy after GLP-1 receptor agonist failure
Bariatric surgery is associated with clinically meaningful two-year weight loss after semaglutide or tirzepatide intolerance or inadequate response, according to a study published online Nov. 3 in the Annals of Surgery .
AI Summary
A study published online on Nov. 3 in the Annals of Surgery found that bariatric surgery leads to clinically meaningful weight loss at two years for patients who could not tolerate or did not respond adequately to GLP‑1 receptor agonists such as semaglutide or tirzepatide. The research indicates that surgical intervention can serve as an effective rescue strategy when these medications fail to produce sufficient weight loss.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- South African trial tests off-the-shelf killer cells against lymphomaContinue reading
- Texas Democrats Swept Statewide Races. Now Comes the Hard Part of Solving Healthcare Angst.Continue reading
- Is shorter daylight dragging down your mood? What to know about seasonal affective disorderContinue reading
- Will RFK Jr. Face Impeachment Under New Congress?Continue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow